Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Colorectal cancer | R-HSA-4791275 | map05210 | acebutolol | 1978 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | acebutolol | 1978 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | diphemanil metilsulfate | 6126 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | diphemanil metilsulfate | 6126 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | diphemanil metilsulfate | 6126 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | diphemanil metilsulfate | 6126 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | diphemanil metilsulfate | 6126 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | diphemanil metilsulfate | 6126 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | diphemanil metilsulfate | 6126 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | diphemanil metilsulfate | 6126 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | diphemanil metilsulfate | 6126 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | amylocaine | 4891 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | amylocaine | 4891 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | amylocaine | 4891 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | amylocaine | 4891 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | amylocaine | 4891 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | amylocaine | 4891 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | amylocaine | 4891 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | amylocaine | 4891 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | amylocaine | 4891 | drug-path |